Biotech / PharmaGreater Boston
Axonis Therapeutics, Inc.
Biotech / Pharma
· Boston, MA
Boston-based biotech developing oral small-molecule KCC2-targeted therapies for epilepsy, chronic pain, and spinal cord injury; closed a $115M Series A in 2024.
Founded
Region
Greater Boston
Investors
People